|
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial |
|
|
|
Titel: |
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial |
Auteur: |
Colombo, Nicoletta Biagioli, Elena Harano, Kenichi Galli, Francesca Hudson, Emma Antill, Yoland Choi, Chel Hun Rabaglio, Manuela Marmé, Frederic Marth, Christian Parma, Gabriella Fariñas-Madrid, Lorena Nishio, Shin Allan, Karen Lee, Yeh Chen Piovano, Elisa Pardo, Beatriz Nakagawa, Satoshi McQueen, John Zamagni, Claudio Manso, Luis Takehara, Kazuhiro Tasca, Giulia Ferrero, Annamaria Tognon, Germana Lissoni, Andrea Alberto Petrella, Mariacristina Laudani, Maria Elena Rulli, Eliana Uggeri, Sara Barretina Ginesta, M Pilar |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 25 () nr. 9 pagina's 1135-1146 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|